or Try an Advanced Search...

    Technical Analysis for PHVS - Pharvaris N.V.

    Grade Last Price % Change Price Change
    F 21.77 -1.52% -0.34
    PHVS closed up 6.25 percent on Wednesday, May 15, 2024, on approximately normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical PHVS trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish -1.52%
    50 DMA Resistance Bearish -1.52%
    Crossed Above 20 DMA Bullish -1.52%
    Narrow Range Bar Range Contraction 4.64%
    20 DMA Resistance Bearish 2.81%
    Outside Day Range Expansion 1.42%
    MACD Bearish Signal Line Cross Bearish 5.81%
    NR7 Range Contraction 5.81%
    Narrow Range Bar Range Contraction 5.81%
    Down 3 Days in a Row Weakness 5.81%
    Older End-of-Day Signals for PHVS ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 3 hours ago
    10 DMA Support about 3 hours ago
    Down 2 % about 3 hours ago
    60 Minute Opening Range Breakdown about 4 hours ago
    Fell Below 10 DMA about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    PHVS Chart by TradingView
    Basic chart:

    Profile

    Pharvaris B.V., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Netherlands.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Rare Diseases Angioedema Hereditary Angioedema Complement Deficiency

    Is PHVS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses
    May 9 Pharvaris reports Q1 results
    May 8 Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update
    Apr 12 Pharvaris files for automatic mixed securities shelf
    Apr 12 Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
    Apr 10 Pharvaris reports Q4 results
    Apr 10 Pharvaris appoints David Nassif as chief financial officer
    Apr 10 Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    Apr 10 Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
    Apr 4 Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
    See more PHVS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.0
    52 Week Low 8.2
    Average Volume 67,373
    200-Day Moving Average 22.30
    50-Day Moving Average 22.73
    20-Day Moving Average 21.91
    10-Day Moving Average 21.84
    Average True Range 1.85
    RSI (14) 49.75
    ADX 10.54
    +DI 22.94
    -DI 17.70
    Chandelier Exit (Long, 3 ATRs) 19.96
    Chandelier Exit (Short, 3 ATRs) 23.11
    Upper Bollinger Bands 25.07
    Lower Bollinger Band 18.74
    Percent B (%b) 0.53
    BandWidth 28.94
    MACD Line -0.33
    MACD Signal Line -0.27
    MACD Histogram -0.0672
    Fundamentals Value
    Market Cap 1.15 Billion
    Num Shares 52.1 Million
    EPS -3.27
    Price-to-Earnings (P/E) Ratio -6.76
    Price-to-Sales 0.00
    Price-to-Book 9.11
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.06
    Resistance 3 (R3) 25.05 24.06 24.56
    Resistance 2 (R2) 24.06 23.31 24.06 24.40
    Resistance 1 (R1) 23.08 22.84 23.57 23.09 24.23
    Pivot Point 22.09 22.09 22.34 22.09 22.09
    Support 1 (S1) 21.11 21.34 21.60 21.12 19.97
    Support 2 (S2) 20.12 20.87 20.12 19.80
    Support 3 (S3) 19.14 20.12 19.64
    Support 4 (S4) 19.15